Cargando...
Endocrine therapy resistance: new insights
The estrogen receptor positive (ER+) subset is the dominant contributor to global deaths from breast cancer which now exceeds 500,000 deaths annually. Lethality is driven by endocrine resistance, which has been shown to be associated with high mutational rates and extreme subclonal diversity. Treatm...
Guardado en:
| Publicado en: | Breast |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6939855/ https://ncbi.nlm.nih.gov/pubmed/31839155 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0960-9776(19)31118-X |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|